Diagnos Laboratorium Utama Tbk. vs Fast Food Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Fast Food Indonesia Tbk. trades at Rp276 (market cap 1.22T, 847.1K 24h volume). The key difference: Fast Food Indonesia Tbk. is far larger — about 3.9× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 847.1K). Which is the better fit depends on your goals.
| DGNS | FAST | |
|---|---|---|
Market Cap | 310.75B | 1.22T |
Volume | 963.6K | 847.1K |
Lot | 9.64K | 8.47K |
Turnover | 217.67M | 227.75M |
Average Price | 225.89 | 268.86 |
Value | 217.67M | 227.75M |
Indicative Equilibrium Price | 226 | 276 |
Indicative Equilibrium Volume | 1K | 13 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT. Fast Food Indonesia Tbk is a company founded in 1978 by the Gelael Group and the exclusive KFC franchise holder in Indonesia. The first KFC outlet opened in October 1979 at Jl. Melawai, Jakarta proved to be successful and paved the way for the opening of more additional outlets in Jakarta. The Company expanded its regional coverage to include other major cities in Indonesia and because of its success in building KFC brand image for the past 20 years of operation, KFC became the country’s dominant fast food market leader.
Read more on FAST →